A cutting-edge review explores the convergence of three-dimensional (3D) printing and peptide self-assembly, unveiling a new era in biomanufacturing. This technology paves the way for creating ...

GelMA is a polymerizable hydrogel material generated from natural extracellular matrix (ECM) components. Gelatin has become popular for tissue engineering applications due to its low cost, ...

TissueFab ® GelMA-Vis-LAP bioink is a gelatin methacryloyl (GelMA)-based bioink designed for 3D bioprinting applications. In this process, LAP is employed as the photoinitiator, facilitating blue ...

Bioprinting is an additive manufacturing (AM) method for producing biological materials that can be used in medicine, as well as other industries. In the latest advance in this relatively new field, ...

As additive manufacturing has continued along the path of maturity, it has become strikingly clear the young technology excels when applied to the custom work of building intricate components. With ...

The 3D printing company's recent acquisition marks its commercial entrance into the burgeoning bioprinting space, in which it had previously been involved only through a research collaboration. While ...

REHOVOT, Israel, Nov. 15, 2021 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue ...

Precision medicine is, broadly speaking, a sweeping aspiration that will be achieved, or not, depending on the convergence of many different disciplines. The most important of these disciplines are ...

(Nanowerk News) Bioprinting is a technology used to create three-dimensional structures, such as human tissues or organs, using bio-inks made of cells and hydrogels. However, conventional inkjet ...

Delray Beach, FL, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The global 3D bioprinting market, valued at US$1.2 billion in 2023, stood at US$1.3 billion in 2024 and is projected to advance at a resilient CAGR ...